High-accuracy determination of internal circadian time from a single blood sample
Authors:
- Nicole WittenbrinkNWNicole Wittenbrink
- Bharath AnanthasubramaniamBABharath Ananthasubramaniam
- Mirjam MünchMMMirjam Münch
- Barbara KollerBKBarbara Koller
- Bert MaierBMBert Maier
- Charlotte WeschkeCWCharlotte Weschke
- Frederik BesFBFrederik Bes
- Jan de ZeeuwJZJan de Zeeuw
- Claudia NowozinCNClaudia Nowozin
- Amely WahnschaffeAWAmely Wahnschaffe
- Sophia WisniewskiSWSophia Wisniewski
- Mandy ZaleskaMZMandy Zaleska
Top Cited Papers
Open Access
- 6 August 2018
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (9) , 3826-3839
Abstract
BACKGROUND. The circadian clock is a fundamental and pervasive biological program that coordinates 24-hour rhythms in physiology, metabolism, and behavior, and it is essential to health. Whereas therapy adapted to time of day is increasingly reported to be highly successful, it needs to be personalized, since internal circadian time is different for each individual. In addition, internal time is not a stable trait, but is influenced by many factors, including genetic predisposition, age, sex, environmental light levels, and season. An easy and convenient diagnostic tool is currently missing. METHODS. To establish a validated test, we followed a 3-stage biomarker development strategy: (a) using circadian transcriptomics of blood monocytes from 12 individuals in a constant routine protocol combined with machine learning approaches, we identified biomarkers for internal time; and these biomarkers (b) were migrated to a clinically relevant gene expression profiling platform (NanoString) and (c) were externally validated using an independent study with 28 early or late chronotypes. RESULTS. We developed a highly accurate and simple assay (BodyTime) to estimate the internal circadian time in humans from a single blood sample. Our assay needs only a small set of blood-based transcript biomarkers and is as accurate as the current gold standard method, dim-light melatonin onset, at smaller monetary, time, and sample-number cost. CONCLUSION. The BodyTime assay provides a new diagnostic tool for personalization of health care according to the patient’s circadian clock. FUNDING. This study was supported by the Bundesministerium für Bildung und Forschung, Germany (FKZ: 13N13160 and 13N13162) and Intellux GmbH, Germany.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (13N13160, 13N13162)
- Intellux GmbH (n.a.)
This publication has 40 references indexed in Scilit:
- Entrainment of the Human Circadian Clock to the Natural Light-Dark CycleCurrent Biology, 2013
- Circadian control of the immune systemNature Reviews Immunology, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Human blood metabolite timetable indicates internal body timeProceedings of the National Academy of Sciences, 2012
- RSeQC: quality control of RNA-seq experimentsBioinformatics, 2012
- A circadian clock in macrophages controls inflammatory immune responsesProceedings of the National Academy of Sciences, 2009
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Epidemiology of the human circadian clockSleep Medicine Reviews, 2007
- External validation is necessary in prediction research:Journal of Clinical Epidemiology, 2003
- The use of Constant Routines in Unmasking the Endogenous Component of Human Circadian RhythmsChronobiology International, 1984